This document provides guidelines for the ventilatory management of acute hypercapnic respiratory failure (AHRF) in adults. It aims to highlight currently suboptimal care for AHRF patients in the UK and promote an integrated care pathway involving multiple clinical teams. The guidelines recommend considering non-invasive ventilation when certain criteria are met for conditions like COPD exacerbations. Intubation should not be delayed if non-invasive ventilation is failing. Organizational coordination between intensive care and other clinical areas is also emphasized to improve outcomes for these patients.
Chronic Obstructive Pulmonary Disease (COPD) by Dr Kemi DeleKemi Dele-Ijagbulu
Presentation on definition and general overview of COPD, how to differentiate COPD from Asthma, how to make diagnosis of COPD, simple tools for assessment of COPD; available therapeutic options; as well as management of stable COPD, COPD exacerbations and comorbidities
Chronic Obstructive Pulmonary Disease (COPD) by Dr Kemi DeleKemi Dele-Ijagbulu
Presentation on definition and general overview of COPD, how to differentiate COPD from Asthma, how to make diagnosis of COPD, simple tools for assessment of COPD; available therapeutic options; as well as management of stable COPD, COPD exacerbations and comorbidities
A cardiologists perspective to current scenario in light of corona pandemic in india and world wide. cardiac procedures , heart disease , aceinhibitors , arni , heart failure , troponin, nt probnp
A cardiologists perspective to current scenario in light of corona pandemic in india and world wide. cardiac procedures , heart disease , aceinhibitors , arni , heart failure , troponin, nt probnp
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Couples presenting to the infertility clinic- Do they really have infertility...
Web Appendix 3 - BTS ICS Guideline Slides.ppt
1. Better Lung Health for All
BTS/ICS Guidelines for the ventilatory
management of acute hypercapnic
respiratory failure in adults
British Thoracic Society
Intensive Care Society
2. Better Lung Health for All
Introduction
• Acute Hypercapnic Respiratory Failure (AHRF) results
in 50,000 admissions each year in the UK
• Without ventilatory support AHRF is associated with
a high mortality rate and a prolonged inpatient stay
• The incidence of AHRF is similar to upper GI
haemorrhage which is, quite rightly, recognised as a
medical emergency and one in which delay in
instituting treatment and poor coordination between
clinical teams increases mortality
3. Better Lung Health for All
Introduction
• Patients with AHRF are not receiving optimal
therapy:
• BTS NIV audit reports 2011-13
• Acidosis, non-invasive ventilation and mortality in hospitalised
COPD exacerbations. Thorax 2011
• National COPD Audit Programme: secondary care clinical audit
report: “Who Cares Matters 2014” https://www.rcplondon.ac.uk/projects/national-
copd-audit-programme
• “provision of NIV is often poorly performed,
patients not treated until acidosis severe and
some patients inappropriately denied admission
to the ICU”
4. Better Lung Health for All
Aims of Guideline
• Highlight current suboptimal care for individuals
with AHRF in the UK
• Review the evidence base for treatment of AHRF
by invasive and non invasive ventilation
• Promote an integrated AHRF care pathway
involving Emergency Departments, Medical
Admission Units, Respiratory Wards & Critical
Care
• Improve patient outcome and experience
5. Better Lung Health for All
AHRF
• May complicate a number of conditions that
affect lungs and/or impair the function of
respiratory pump
• Airway disease : COPD, asthma, Cystic fibrosis
and non-CF bronchiectasis
• Respiratory pump : neuromuscular disease, chest
wall deformity and morbid obesity
• AHRF may be acute or acute on chronic
6. Better Lung Health for All
Acute exacerbations COPD
• Commonest cause of AHRF : 20% AECOPD
• In COPD signals advanced disease, high risk of
future hospitalisations and limited long term
prognosis
• In COPD mortality 8% without AHRF and up to
30% with AHRF depending on the degree of
acidosis
7. Better Lung Health for All
In all causes AHRF
Development of AHRF warrants a change in
future care arrangements:
• predicts future life threatening episodes
• indicates need, in some, for domiciliary NIV
8. Better Lung Health for All
Treatment of AHRF
Prior to availability of non-invasive ventilation:
• intubation was required when conventional
treatment failed
• unclear what criteria guided recognition of this
need …...intubation variably offered
internationally……limited availability of intensive
care beds in UK reduced access to this option
9. Better Lung Health for All
Prognostic indicators
• Mostly investigated in AECOPD, where outcome less good in
those with adverse features, especially when multiple
• Medical staff infrequently use formal severity scoring and
consistently under-estimate survival potential
• Scoring poorly predictive on individual basis and, on its own,
little help in deciding when mechanical ventilation would be
futile
• Important that potentially life-saving treatment, including NIV,
not inappropriately withheld
10. Better Lung Health for All
Recommendations (1):
Prevention AHRF
• Oxygen should be used with care in all individuals at
risk of AHRF
• Use a target oxygen saturation range of 88-92% in
ALL self-ventilating patients at risk of AHRF
• If oxygen indicated, start at 24-28% oxygen via a
Venturi mask
11. Better Lung Health for All
Recommendations (2):
NIV
• Consider starting NIV when pH < 7.35, PCO2 > 6.5
kPa and respiratory rate > 23
• Consider starting NIV in hypercapnic NMD or CWD
patients in the absence acidosis
• NIV should not be used in acute hypercapnic asthma
• Do not delay starting NIV or continue with it when
the patient is deteriorating as both increase
mortality.
12. Better Lung Health for All
• The use of NIV should not delay escalation to
IMV when this is more appropriate
• Intubation is indicated if NIV is failing (unless it
is not desired by the patient or agreed not in
his/her “best interest”)
• Be aware that clinicians can underestimate
survival potential in AHRF treated by IMV
Recommendations (3):
Invasive Ventilation
13. Better Lung Health for All
Recommendations (4):
NIV in the ICU
• Patients with higher risk of NIV failure can be
predicted and should be considered for direct
admission to ICU
• In many AHRF patients the planned use of NIV post
extubation reduces the need for re-intubation
• In COPD, and in many individuals with NM disease,
NIV-supported extubation should be employed in
preference to inserting a tracheostomy
14. Better Lung Health for All
Recommendations (5):
Organisational aspects
Be aware:
• A care environment with level 2 equivalence
improves the outcome of NIV
• Ward-based NIV risks greater delay in expert
review and/or escalation to IMV
• Coordination of care between the ICU and other
patient areas improves outcome
15. Better Lung Health for All
Recommendations (6):
Governance and risk avoidance
• Care planning is needed between respiratory,
emergency and acute care physicians and the ICU
• A senior clinician should lead in the local production
of a seamless AHRF patient pathway
• Episodes of oxygen toxicity, or unexpected death
whilst on NIV, should be critically reported
• Rolling programmes of staff training and auditing of
performance in AHRF improves outcomes
17. Better Lung Health for All
Figure 2 Guide to initial settings and aims with imv
18. Better Lung Health for All
Figure 3: The three phases of patient management in AHRF
19. Better Lung Health for All
Further information
The guideline can be found on the BTS website at:
https://www.brit-thoracic.org.uk/guidelines-and-
quality-standards/ventilatory-management-of-
acute-hypercapnic-respiratory-failure-guideline/
Contact: bts@brit-thoracic.org.uk